Group Purchasing Organizations (GPOs) gather the buying needs of hospitals that belong to them. This leads to larger orders. With bigger orders, they can get lower prices from manufacturers and sellers. This helps hospitals save money on supplies. Studies show that if a GPO grows bigger, hospitals can spend about 2.7% less on supplies for each patient they treat. That means saving nearly $48 per patient and about $720,000 each year for an average hospital.
Hospitals that join larger GPOs might save even more. They could cut supply costs by about 4.8% per patient, which is $85 less for each patient, or more than $1.2 million in a year. These savings help hospitals lower their overall costs, especially since hospital care makes up over 30% of all healthcare spending in the U.S. Supplies are one of the biggest parts of these costs after paying staff.
Importantly, these savings do not lower the quality of care. Hospitals still provide good treatment and do not limit which patients they accept. In areas where hospitals compete a lot, some savings are passed to patients as lower hospital prices.
Despite the benefits of GPOs, they face new problems. More hospitals are making deals directly with manufacturers instead of using GPOs. One example is Medtronic, a big company that makes medical devices for heart and bone treatments. They ended five contracts with Novation, the biggest GPO, that were worth about $2 billion a year.
This move shows a trend where large or combined hospital systems use their size to bargain directly with makers. By doing this, they skip GPOs and get deals suited to their needs. For manufacturers, direct deals can be better because they do not have to share profits with GPOs and can offer more flexible terms.
Medtronic’s $2 billion in sales is about 5% of Novation’s total purchases. This shows how much such decisions can affect GPOs. If other makers do the same, GPOs could lose a lot of their power and income.
Another big change is that many hospitals are joining into larger systems. More than half of doctor offices are now owned by hospitals. These big health systems have more power to make deals. They often pick a set of products to use in all their places and make contracts directly with sellers. This lowers their need for GPOs.
With bigger hospital systems, contracts become more complex. Hospitals want services that fit their many departments and structure. GPOs have to change too. They need to offer special contracts and services that match what big hospital systems want.
This trend means fewer but larger buyers control the market. They want to work directly with manufacturers and sellers for the best deals, instead of using GPO contracts designed for many members.
GPOs also compete with big wholesalers and Pharmacy Benefit Managers (PBMs). These groups take over areas that GPOs used to handle. Wholesalers both buy from and compete with GPOs, especially for generic drugs and medical supplies.
PBMs focus more on “buy-and-bill” drugs. These are specialty and injectable medicines that doctors buy to give patients and then ask insurers to pay separately. PBMs try to lower the difference between what providers pay for these drugs and what they get reimbursed. This hurts the profits of distributors, pharmacies, and GPOs.
This competition makes it harder for GPOs to earn money from supplier fees based on contract size. Managing drug spending and specialty medicines is more complex now. GPOs must find new ways to stay important in these areas.
Besides saving money, GPOs also help hospitals with managing contracts and order processes. But new IT tools reduce this need. Many tasks like contract tracking, vendor relations, and buying data analysis can now be done with hospital computer systems.
Jim Fields, who studies healthcare supply chains, says GPOs do less admin work now because hospitals use more automation and smart tools. This means GPOs must find new reasons to charge fees and prove their value.
More hospital-owned doctor offices mean GPOs have to try new contract ideas and offer extra services beyond bulk buying. They might give advice or special data reports to help supply chains. But these need skills and new technology.
At the same time, automation and Artificial Intelligence (AI) are being used more in healthcare supply and admin work. Practice managers and IT staff use AI tools to make buying supplies easier, more accurate, and cheaper.
AI helps in many ways: predicting what supplies are needed, choosing vendors, and checking contract rules. It looks at past buying data and market trends to guess needs and order the right amounts. This stops waste and avoids running out of supplies. Good forecasting helps hospitals get better direct deals by showing clear data on usage and stock.
AI can also automate routine tasks like approving orders, handling invoices, and talking with vendors. This reduces human mistakes and makes work faster. Using AI and automation helps hospitals control costs while working efficiently.
For GPOs to stay useful, they might need to add AI tools to their services. AI can offer real-time data, buying advice, and automate reports. These tech services can make GPOs stand out in a market where more hospitals contract directly and manage supplies inside.
People who run medical practices in the U.S. should think carefully about how they buy supplies. Practice managers and owners need to check if their GPOs still give the best value, especially as hospitals get bigger and contracts change.
A good strategy is to look at big GPOs because they often deliver more savings. But managers should also consider direct deals with manufacturers, mainly for products bought in large amounts or special items. These deals might offer better prices and services.
IT managers have a key job in using digital tools to improve buying processes. Putting AI and automation into the supply chain helps make buying smoother, data more correct, and save money. Linking these tools with hospital finance and stock systems supports better choices and contract handling.
Healthcare buyers need to balance using group buying power with direct deals that may save more money. Using data and technology is important in making the best decisions.
Healthcare buying in the U.S. is changing. Group Purchasing Organizations face challenges from direct deals with makers like Medtronic, bigger hospital systems, and rivals like wholesalers and PBMs. GPOs still help hospitals save money, but their admin role is shrinking because of new technology. Hospitals and medical practices should think about using AI and automation to improve supply buying and management in this new market situation.
Medtronic canceled five contracts for cardiovascular and orthopedic products with Novation, amounting to a total annual value of $2 billion, raising concerns about the future of GPOs.
GPOs pool purchase volumes from member hospitals to negotiate lower prices with manufacturers and wholesalers, providing administrative support and contract management.
GPOs face several threats, including hospital system consolidations allowing direct manufacturer negotiations, competition with wholesalers, adapting to new service demands from hospital-owned physician practices, and challenges from pharmacy benefit managers (PBMs).
Medtronic’s direct contracting approach questions the GPO business model, potentially prompting other manufacturers to reconsider their relationships with GPOs, thereby threatening the latter’s viability.
The top GPOs include Novation ($37.8B), Premier ($36.0B), MedAssets/Broadlane ($35.0B), HealthTrust Purchasing Group ($17.0B), and Amerinet ($7.2B).
Medtronic’s $2 billion in contracts represents approximately 5% of Novation’s total purchasing volume.
A weaker GPO industry could benefit wholesalers, such as Cardinal Health, by increasing their market power and allowing them to compete more effectively.
Hospital systems are consolidating, gaining leverage to negotiate directly with manufacturers, which could diminish the influence and relevance of GPOs.
With more than half of physician practices now hospital-owned, GPOs need to provide new services and contracting methods to cater to this changing landscape.
PBMs are targeting ‘buy-and-bill’ drug spending, potentially reducing the necessity for GPOs in drug pricing and contracting, which could further erode GPO influence.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
